Multi-level marketing company Herbalife Nutrition Ltd will pay $123.1 million to settle criminal and civil charges for bribing Chinese officials in government agencies and media outlets from 2007 to 2016.
Herbalife will pay $55.74 million in criminal fine, and $67.31 million in disgorgement and interest in a related civil case under the US Securities and Exchange Commission.
According to Acting US Attorney Audrey Strauss, Herbalife approved “extensive and systematic corrupt payments” to Chinese officials, while falsifying records to make its bribes appear as legitimate business expenses.
The company allegedly gave cash, and perks on entertainment, meals, and travel to obtain direct selling licenses, reduce government scrutiny, and suppress negative coverage by state-controlled media.
US Department of Justice said that Herbalife Nutrition entered a three-year deferred prosecution agreement where it admitted conspiring to violate the books and records provision of the anti-bribery law Foreign Corrupt Practices Act.
The multi-level marketing company's products include dietary supplements.
China accounted for 19 percent of Herbalife’s $4.49 billion of net sales in 2016, up from 7 percent in 2006.


Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 



